AGIO SCHEDULE 13G/A: SEC filing

Lynx1 Capital Management LP

Filed with the SEC on · accession 0000902664-26-004571

AGIO filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 16, 2026. Lynx1 Capital Management LP filed an amended Schedule 13G reporting beneficial ownership of 472,606 shares, or 0.8%, of Agios Pharmaceuticals common stock as of September 30, 2026. The stock moved -4.6% by the first close after the filing.

Summary of the filing

Lynx1 Capital Management LP filed an amended Schedule 13G reporting beneficial ownership of 472,606 shares, or 0.8%, of Agios Pharmaceuticals common stock as of September 30, 2026. The filing is passive in nature and does not indicate any intent to influence control of the company.

Key details

Shares of common stock beneficially owned$473K
Percentage of class beneficially owned$1
Reporting person / investment managerLynx1 Capital Management LP
IssuerAgios Pharmaceuticals, Inc.
Sole member of lynx1 capital management gp llcWeston Nichols

How AGIO stock reacted

Close before

$31.59

Nov 13, 2026

First close after

-4.56%

$30.15

5 trading days

—

Since filing

—

✦ Ask GOAX AI about this filing — what it means for AGIO, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for AGIO?

Click here

Frequently asked questions

What did AGIO file with the SEC on Nov 16, 2026?

AGIO filed a SCHEDULE 13G/A (SEC filing). Lynx1 Capital Management LP filed an amended Schedule 13G reporting beneficial ownership of 472,606 shares, or 0.8%, of Agios Pharmaceuticals common stock as of September 30, 2026. The filing is passive in nature and does not indicate any intent to influence control of the company.

How do I read a SCHEDULE 13G/A?

A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).

How did AGIO stock react to this filing?

AGIO closed at $31.59 before the filing and $30.15 on Nov 16, 2026 (-4.56%).

Other AGIO SEC filings

Get alerts when AGIO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days